These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29379644)

  • 1. Update on new research in Gram-negative infections European Congress of Clinical Microbiology and Infectious Diseases 2017 (22-25 April, Vienna, Austria).
    Bassetti M; Mayor S
    Future Sci OA; 2018 Feb; 4(2):FSO270. PubMed ID: 29379644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenems in the treatment of intra-abdominal infection. Report from the 20th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 10-13 April 2010.
    Lumb J
    Future Microbiol; 2010 Aug; 5(8):1165-6. PubMed ID: 20722595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A report from the 20th European Congress of Clinical Microbiology and Infectious Diseases (April 10-13, 2010 - Vienna, Austria).
    Rabasseda X
    Drugs Today (Barc); 2010 Jul; 46(7):533-42. PubMed ID: 20683506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Ceftolozane/Tazobactam Against Gram-Negative Rods of the Family Enterobacteriaceae and Pseudomonas Spp. Isolated from Onco-Hematological Patients Hospitalized in a Clinical Hospital in Poland.
    Saran O; Sulik-Tyszka B; Basak GW; Wróblewska MM
    Med Sci Monit; 2019 Jan; 25():305-311. PubMed ID: 30628586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes in the management of Gram-negative bacterial infections in the face of growing antimicrobial resistance.
    Mayor S
    Future Microbiol; 2016 Oct; 11():1223-1226. PubMed ID: 27680185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
    Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
    Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan.
    Kuntaman K; Shigemura K; Osawa K; Kitagawa K; Sato K; Yamada N; Nishimoto K; Yamamichi F; Rahardjo D; Hadi U; Mertaniasih NM; Kinoshita S; Fujisawa M; Shirakawa T
    Int J Urol; 2018 Nov; 25(11):966-972. PubMed ID: 30253445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abstracts of the 20th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). Vienna, Austria. April 10-13, 2010.
    Clin Microbiol Infect; 2010 Apr; 16 Suppl 2(Suppl 2):S1-720. PubMed ID: 20412063
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on Clostridium difficile from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, April 22-25, 2017.
    Davies K; Freeman J; Mayor S
    J Hosp Infect; 2018 Jan; 98(1):1-3. PubMed ID: 29203446
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lob SH; Karlowsky JA; Young K; Motyl MR; Hawser S; Kothari ND; Sahm DF
    J Med Microbiol; 2020 Feb; 69(2):207-217. PubMed ID: 31976856
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012.
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Int J Antimicrob Agents; 2014 Apr; 43(4):328-34. PubMed ID: 24630306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and molecular characterization of carbapenemase-producing gram-negative bacteria from a university hospital in China.
    Sun Y; Li M; Chen L; Chen H; Yu X; Ye J; Zhang Y; Ma C; Zhou T
    Infect Dis (Lond); 2016 Feb; 48(2):138-46. PubMed ID: 26463362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting antibiotic resistance all over Europe.
    Tacconelli E; De Angelis G
    Expert Rev Anti Infect Ther; 2010 Jul; 8(7):761-3. PubMed ID: 20586561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Know your enemy: managing resistant Gram-negative infections.
    Eckmann C; Rojas LJ; Lyon S
    Future Microbiol; 2018 Oct; 13():1457-1460. PubMed ID: 30311790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in-house and commercial real time-PCR based carbapenemase gene detection methods in Enterobacteriaceae and non-fermenting gram-negative bacterial isolates.
    Smiljanic M; Kaase M; Ahmad-Nejad P; Ghebremedhin B
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):48. PubMed ID: 28693493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
    Sader HS; Farrell DJ; Castanheira M; Flamm RK; Jones RN
    J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.
    Song W; Hong SG; Yong D; Jeong SH; Kim HS; Kim HS; Kim JS; Bae IK
    Ann Lab Med; 2015 Mar; 35(2):212-9. PubMed ID: 25729723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.